André Scheen

Researcher Next ID · RN-007813

Researcher · Medicine

Liège, Belgium

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Diabetes Treatment and Management

Diabetes Management and Research

Diet and metabolism studies

Pharmacology and Obesity Treatment

Metabolism, Diabetes, and Cancer

Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
Diabetes Research and Clinical Practice · 2014 · https://doi.org/10.1016/j.diabres.2014.04.006
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
The Lancet · 2006 · https://doi.org/10.1016/s0140-6736(06)69571-8
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
The Lancet · 2005 · https://doi.org/10.1016/s0140-6736(05)67528-9
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
The Lancet · 2005 · https://doi.org/10.1016/s0140-6736(05)66374-x
Clinical Pharmacokinetics of Metformin
Clinical Pharmacokinetics · 1996 · https://doi.org/10.2165/00003088-199630050-00003

No projects listed.